Document:

<PAGE>

Exhibit 10.1

                                 Villa Noble S.L

February 27, 2004

GlobeLink Capital, Inc.
222 Amalfi Drive
Santa Monica, California 90402

Attention: Mr. Keith Berglund,
           President
                            Re: Proposed Investment -
                                 Euro 50 million
Gentlemen:

Pursuant to our meeting today with your representatives, Bruce W. Barren and
Felizian (Phil) Paul here in Munich (Germany), Villa Noble S.L. is prepared to
introduce to its 1,000,000 European investor base the following proposal:

Fund Purpose               To provide capital to Chinese companies under
                           Ministry of Information Industry as entry gateway for
                           non- Chinese companies into China.

Amount:                    Euro 50,000,000

Minimum Offering           Euro 10,000,000

Unit Size                  Euro 50,000 - 1,000 Units

Type of Security:          Secured, Preferred Stock

Dividend Rate              To be guaranteed by investment rated, international
                           financial institution- 5% Annually, payable in four
                           quarterly payments, in arrears five years

Term:                      five years

Use of Proceeds            First Euro 10,000,000:
                           GlobeLink: Euro 5,000,000

                   Centro Plaza 29660 Nuevo Andalucia, Marbella
                  Tel: (34) 952-81 44 71 Fax: (34) 952-81 51 20
                       e-mail: villanoble@infonegocio.com

<PAGE>

                                           Global Medical Products Holding, Inc.

                           - Euro 5,000,000 for a 10% Equity Interest, of which
                           Euro 2,500,000 is to be invested in EarthNetMedia,
                           Inc. for a 5% interest

                           Next, Euro 5,000,000 to be invested in Global Medical
                           for an additional 10% Interest therein, of which Euro
                           2,500,000 to be invested in EarthNetMedia for an
                           additional 5% interest therein.

Special Dividend Distribution
                           For each investment made by GlobeLink, excluding the
                           above investment in Global Medical, GlobeLink
                           Shareholders will receive a special Dividend of 25%
                           of the equity received for such investment.

Covenant(s)                Individual investments by GlobeLink shall be limited
                           to 70% of the independently appraised Tangible and
                           Intangible Assets of the company in which the
                           investment is made. Such investments shall be secured
                           by these assets.

                           On every investment made by GlobeLink, they will
                           cause all intangible assets of the invested company
                           to be registered as trademarks or patents, both in
                           China and Worldwide, where feasible.

                           On every investment made by GlobeLink, EarthNetMedia
                           will receive 5% of such proceeds to insure media
                           coverage.

Public Stock Registration  GlobeLink, through Global Medical, will cause its
                           preferred and common stock to be registered and free
                           trading at the time of the initial placement of Euro
                           10 million to Villa Noble's investors, including each
                           incremental investment thereof to Euro 50 million.
                           Where feasible, GlobeLink will cause each individual
                           investment made by GlobeLink to be a publicly- traded
                           company unto itself.

<PAGE>

Villa Noble S.L.

GlobeLink will grant to Villa Noble the exclusive right in this placement and
will undertake no other concurrent placement of its equity securities. As
compensation, GlobeLink will grant Villa Noble's primary agent, Mr. Eduard
Wittner a 10% equity interest in GlobeLink Capital upon the completion of the
above Placement. Further, GlobeLink will be responsible of the Investment
Memorandum, as outlined per above, plus a website concerning key information on
the Company, including a copy of its Exclusive Agreement with the Ministry of
Information Industry, of which the net Euro 40 million will be used to fulfill
the contact requirements thereunder.

GlobeLink Capital will reserve two additional 10% interest of its equity for a
Chinese and a U.S. / European Financial Institution to become a participant in
its equity, with current shareholders diluted accordingly. Further, Eduard
Wittner (or his designee) will become the European representative of GlobeLink
Capital.

By GlobeLink investing in Global Medical and EarthNet, GlobeLink will cause both
companies to become fully NASDAQ listed.

If you are in agreement with the above, please sign your acceptance of this
agreement in the space provided below.

Cordially,                                  Agreed and accepted by:

Villa Noble S.L.                            GlobeLink Capital, Inc.

/s/ Eduard H. Wittner                       /s/ Bruce W. Barren
------------------------------              -----------------------------
Eduard H. Wittner                           Bruce W. Barren,
Consejero Delgado                           Authorized Representative

GLOBAL MEDICAL PRODUCTS HOLDINGS, INC.      EARTHNET MEDIA, INC.

/s/ Bruce W. Barren                         /s/ Felizian Paul
------------------------------              -----------------------------
Bruce W. Barren,                            Felizian (Phil) Paul,
Authorized Representative                   Chairman

                                Villa Noble S.L.<PAGE>
                                                                   EXHIBIT 10.27

                               INDEMNITY AGREEMENT

         THIS AGREEMENT is made and entered into this 16th day of January, 2004
by and between MYOGEN, INC., a Delaware corporation (the "Corporation"), and
Kirk C. Calhoun ("Agent").

                                    RECITALS

         WHEREAS, Agent performs a valuable service to the Corporation in his
capacity as director of the Corporation;

         WHEREAS, the stockholders of the Corporation have adopted bylaws (the
"Bylaws") providing for the indemnification of the directors, officers,
employees and other agents of the Corporation, including persons serving at the
request of the Corporation in such capacities with other corporations or
enterprises, as authorized by the Delaware General Corporation Law, as amended
(the "Code");

         WHEREAS, the Bylaws and the Code, by their non-exclusive nature, permit
contracts between the Corporation and its agents, officers, employees and other
agents with respect to indemnification of such persons; and

         WHEREAS, in order to induce Agent to serve as director of the
Corporation, the Corporation has determined and agreed to enter into this
Agreement with Agent;

         NOW, THEREFORE, in consideration of Agent's service as director after
the date hereof, the parties hereto agree as follows:

                                    AGREEMENT

         1. SERVICES TO THE CORPORATION. Agent will serve, at the will of the
Corporation or under separate contract, if any such contract exists, as director
of the Corporation or as a director, officer or other fiduciary of an affiliate
of the Corporation (including any employee benefit plan of the Corporation)
faithfully and to the best of his ability so long as he is duly elected and
qualified in accordance with the provisions of the Bylaws or other applicable
charter documents of the Corporation or such affiliate; provided, however, that
Agent may at any time and for any reason resign from such position (subject to
any contractual obligation that Agent may have assumed apart from this
Agreement) and that the Corporation or any affiliate shall have no obligation
under this Agreement to continue Agent in any such position.

         2. INDEMNITY OF AGENT. The Corporation hereby agrees to hold harmless
and indemnify Agent to the fullest extent authorized or permitted by the
provisions of the Bylaws and the Code, as the same may be amended from time to
time (but, only to the extent that such amendment permits the Corporation to
provide broader indemnification rights than the Bylaws or the Code permitted
prior to adoption of such amendment).

                                       1.
<PAGE>

         3. ADDITIONAL INDEMNITY. In addition to and not in limitation of the
indemnification otherwise provided for herein, and subject only to the
exclusions set forth in Section 4 hereof, the Corporation hereby further agrees
to hold harmless and indemnify Agent:

                  (a) against any and all expenses (including attorneys' fees),
witness fees, damages, judgments, fines and amounts paid in settlement and any
other amounts that Agent becomes legally obligated to pay because of any claim
or claims made against or by him in connection with any threatened, pending or
completed action, suit or proceeding, whether civil, criminal, arbitrational,
administrative or investigative (including an action by or in the right of the
Corporation) to which Agent is, was or at any time becomes a party, or is
threatened to be made a party, by reason of the fact that Agent is, was or at
any time becomes a director, officer, employee or other agent of Corporation, or
is or was serving or at any time serves at the request of the Corporation as a
director, officer, employee or other agent of another corporation, partnership,
joint venture, trust, employee benefit plan or other enterprise; and

                  (b) otherwise to the fullest extent as may be provided to
Agent by the Corporation under the non-exclusivity provisions of the Code and
Section 41 of the Bylaws.

         4. LIMITATIONS ON ADDITIONAL INDEMNITY. No indemnity pursuant to
Section 3 hereof shall be paid by the Corporation:

                  (a) on account of any claim against Agent for an accounting of
profits made from the purchase or sale by Agent of securities of the Corporation
pursuant to the provisions of Section 16(b) of the Securities Exchange Act of
1934 and amendments thereto or similar provisions of any federal, state or local
statutory law;

                  (b) on account of Agent's conduct that is established by a
final judgment as knowingly fraudulent or deliberately dishonest or that
constituted willful misconduct;

                  (c) on account of Agent's conduct that is established by a
final judgment as constituting a breach of Agent's duty of loyalty to the
Corporation or resulting in any personal profit or advantage to which Agent was
not legally entitled;

                  (d) for which payment is actually made to Agent under a valid
and collectible insurance policy or under a valid and enforceable indemnity
clause, bylaw or agreement, except in respect of any excess beyond payment under
such insurance, clause, bylaw or agreement;

                  (e) if indemnification is not lawful (and, in this respect,
both the Corporation and Agent have been advised that the Securities and
Exchange Commission believes that indemnification for liabilities arising under
the federal securities laws is against public policy and is, therefore,
unenforceable and that claims for indemnification should be submitted to
appropriate courts for adjudication); or

                  (f) in connection with any proceeding (or part thereof)
initiated by Agent, or any proceeding by Agent against the Corporation or its
directors, officers, employees or other agents, unless (i) such indemnification
is expressly required to be made by law, (ii) the proceeding was authorized by
the Board of Directors of the Corporation, (iii) such indemnification is
provided by the Corporation, in its sole discretion, pursuant to the powers

                                       2.
<PAGE>

vested in the Corporation under the Code, or (iv) the proceeding is initiated
pursuant to Section 9 hereof.

         5. CONTINUATION OF INDEMNITY. All agreements and obligations of the
Corporation contained herein shall continue during the period Agent is a
director, officer, employee or other agent of the Corporation (or is or was
serving at the request of the Corporation as a director, officer, employee or
other agent of another corporation, partnership, joint venture, trust, employee
benefit plan or other enterprise) and shall continue thereafter so long as Agent
shall be subject to any possible claim or threatened, pending or completed
action, suit or proceeding, whether civil, criminal, arbitrational,
administrative or investigative, by reason of the fact that Agent was serving in
the capacity referred to herein.

         6. PARTIAL INDEMNIFICATION. Agent shall be entitled under this
Agreement to indemnification by the Corporation for a portion of the expenses
(including attorneys' fees), witness fees, damages, judgments, fines and amounts
paid in settlement and any other amounts that Agent becomes legally obligated to
pay in connection with any action, suit or proceeding referred to in Section 3
hereof even if not entitled hereunder to indemnification for the total amount
thereof, and the Corporation shall indemnify Agent for the portion thereof to
which Agent is entitled.

         7. NOTIFICATION AND DEFENSE OF CLAIM. Not later than thirty (30) days
after Agent becomes aware, by written or other overt communication, of any
pending or threatened litigation, claim or assessment, Agent will, if a claim in
respect thereof is to be made against the Corporation under this Agreement,
notify the Corporation of such pending or threatened litigation, claim or
assessment; but the omission so to notify the Corporation will not relieve it
from any liability which it may have to Agent otherwise than under this
Agreement. With respect to any such pending or threatened litigation, claim or
assessment as to which Agent notifies the Corporation of the commencement
thereof:

                  (a) the Corporation will be entitled to participate therein at
its own expense;

                  (b) except as otherwise provided below, the Corporation may,
at its option and jointly with any other indemnifying party similarly notified
and electing to assume such defense, assume the defense thereof, with counsel
reasonably satisfactory to Agent. After notice from the Corporation to Agent of
its election to assume the defense thereof, the Corporation will not be liable
to Agent under this Agreement for any legal or other expenses subsequently
incurred by Agent in connection with the defense thereof except for reasonable
costs of investigation or otherwise as provided below. Agent shall have the
right to employ separate counsel in such action, suit or proceeding but the fees
and expenses of such counsel incurred after notice from the Corporation of its
assumption of the defense thereof shall be at the expense of Agent unless (i)
the employment of counsel by Agent has been authorized by the Corporation, (ii)
Agent shall have reasonably concluded, and so notified the Corporation, that
there is an actual conflict of interest between the Corporation and Agent in the
conduct of the defense of such action or (iii) the Corporation shall not in fact
have employed counsel to assume the defense of such action, in each of which
cases the fees and expenses of Agent's separate counsel shall be at the expense
of the Corporation. The Corporation shall not be entitled to assume the defense
of

                                       3.
<PAGE>

any action, suit or proceeding brought by or on behalf of the Corporation or as
to which Agent shall have made the conclusion provided for in clause (ii) above;
and

                  (c) the Corporation shall not be liable to indemnify Agent
under this Agreement for any amounts paid in settlement of any action or claim
effected without its written consent, which shall not be unreasonably withheld.
The Corporation shall be permitted to settle any action or claim except that it
shall not settle any action or claim in any manner which would impose any
penalty or limitation on Agent without Agent's written consent, which may be
given or withheld in Agent's sole discretion.

         8. EXPENSES. The Corporation shall advance, prior to the final
disposition of any proceeding, promptly following request therefor, all expenses
incurred by Agent in connection with such proceeding upon receipt of an
undertaking by or on behalf of Agent to repay said amounts if it shall be
determined ultimately that Agent is not entitled to be indemnified under the
provisions of this Agreement, the Bylaws, the Code or otherwise.

         9. ENFORCEMENT. Any right to indemnification or advances granted by
this Agreement to Agent shall be enforceable by or on behalf of Agent in any
court of competent jurisdiction if (i) the claim for indemnification or advances
is denied, in whole or in part, or (ii) no disposition of such claim is made
within ninety (90) days of request therefor. Agent, in such enforcement action,
if successful in whole or in part, shall be entitled to be paid also the expense
of prosecuting his claim. It shall be a defense to any action for which a claim
for indemnification is made under Section 3 hereof (other than an action brought
to enforce a claim for expenses pursuant to Section 8 hereof, provided that the
required undertaking has been tendered to the Corporation) that Agent is not
entitled to indemnification because of the limitations set forth in Section 4
hereof. Neither the failure of the Corporation (including its Board of Directors
or its stockholders) to have made a determination prior to the commencement of
such enforcement action that indemnification of Agent is proper in the
circumstances, nor an actual determination by the Corporation (including its
Board of Directors or its stockholders) that such indemnification is improper
shall be a defense to the action or create a presumption that Agent is not
entitled to indemnification under this Agreement or otherwise.

         10. SUBROGATION. In the event of payment under this Agreement, the
Corporation shall be subrogated to the extent of such payment to all of the
rights of recovery of Agent, who shall execute all documents required and shall
do all acts that may be necessary to secure such rights and to enable the
Corporation effectively to bring suit to enforce such rights.

         11. NON-EXCLUSIVITY OF RIGHTS. The rights conferred on Agent by this
Agreement shall not be exclusive of any other right which Agent may have or
hereafter acquire under any statute, provision of the Corporation's Certificate
of Incorporation or Bylaws, agreement, vote of stockholders or directors, or
otherwise, both as to action in his official capacity and as to action in
another capacity while holding office.

         12. SURVIVAL OF RIGHTS.

                  (a) The rights conferred on Agent by this Agreement shall
continue after Agent has ceased to be a director, officer, employee or other
agent of the Corporation or to serve

                                       4.
<PAGE>

at the request of the Corporation as a director, officer, employee or other
agent of another corporation, partnership, joint venture, trust, employee
benefit plan or other enterprise and shall inure to the benefit of Agent's
heirs, executors and administrators.

                  (b) The Corporation shall require any successor (whether
direct or indirect, by purchase, merger, consolidation or otherwise) to all or
substantially all of the business or assets of the Corporation, expressly to
assume and agree to perform this Agreement in the same manner and to the same
extent that the Corporation would be required to perform if no such succession
had taken place.

         13. SEPARABILITY. Each of the provisions of this Agreement is a
separate and distinct agreement and independent of the others, so that if any
provision hereof shall be held to be invalid for any reason, such invalidity or
unenforceability shall not affect the validity or enforceability of the other
provisions hereof. Furthermore, if this Agreement shall be invalidated in its
entirety on any ground, then the Corporation shall nevertheless indemnify Agent
to the fullest extent provided by the Bylaws, the Code or any other applicable
law.

         14. GOVERNING LAW. This Agreement shall be interpreted and enforced in
accordance with the laws of the State of Delaware.

         15. AMENDMENT AND TERMINATION. No amendment, modification, termination
or cancellation of this Agreement shall be effective unless in writing signed by
both parties hereto.

         16. IDENTICAL COUNTERPARTS. This Agreement may be executed in one or
more counterparts, each of which shall for all purposes be deemed to be an
original but all of which together shall constitute but one and the same
Agreement. Only one such counterpart need be produced to evidence the existence
of this Agreement.

         17. HEADINGS. The headings of the sections of this Agreement are
inserted for convenience only and shall not be deemed to constitute part of this
Agreement or to affect the construction hereof.

         18. NOTICES. All notices, requests, demands and other communications
hereunder shall be in writing and shall be deemed to have been duly given (i)
upon delivery if delivered by hand to the party to whom such communication was
directed or (ii) upon the third business day after the date on which such
communication was mailed if mailed by certified or registered mail with postage
prepaid:

                  (a) If to Agent, at the address indicated on the signature
page hereof.

                  (b) If to the Corporation, to:

                           Myogen, Inc.
                           7575 West 103rd Avenue, Suite 102
                           Westminster, CO  80021

or to such other address as may have been furnished to Agent by the Corporation.

                                       5.
<PAGE>

         IN WITNESS WHEREOF, the parties hereto have executed this Agreement on
and as of the day and year first above written.

                                    MYOGEN, INC.

                                    By: /s/ J. William Freytag
                                       -----------------------------------------

                                    Title: Chief Executive Officer

                                    AGENT

                                    /s/ Kirk C. Calhoun
                                    --------------------------------------------
                                    Kirk C. Calhoun

                                       6.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00061-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00061-of-00352.parquet"}]]